10 results
8-K
EX-1.1
ATXI
Avenue Therapeutics Inc
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
and privileges described in the Registration Statement, the Disclosure Package and the Prospectus referred to below. The offering and sale of the Securities … .
“Disclosure Package” means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time, the Preliminary Prospectus dated
8-K
EX-1.1
ATXI
Avenue Therapeutics Inc
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm
and privileges described in the Registration Statement, the Disclosure Package and the Prospectus referred to below. The offering and sale of the Securities … .
“Disclosure Package” means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time, the Preliminary Prospectus dated
8-K
EX-1.1
ATXI
Avenue Therapeutics Inc
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
in the Registration Statement prior to the time at which the Commission declared the Registration Statement effective.
“Pricing Disclosure Package” means … ), the Pricing Disclosure Package, the Final Prospectus (including any amendments or supplements thereto), any Preliminary Prospectus, any Issuer Free Writing
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
Prospectus, as the case may be. As used in this paragraph and elsewhere in this Agreement, “Time of Sale Disclosure Package” means the Preliminary Prospectus … Disclosure Package. The term “any Prospectus” shall mean, as the context requires, the Preliminary Prospectus, the Final Prospectus, and any supplement
8-K
z4o85atk42dcw gzt6d7
1 Mar 21
Other Events
7:30am
FWP
44nwamcejqmav6ra3
6 Oct 22
Free writing prospectus
4:05pm
PREM14A
fjcr3oiboha7eiw
11 Dec 18
Preliminary proxy related to merger
5:23pm
DEFM14A
x6limd30 ofvi
21 Dec 18
Proxy related to merger
12:23pm
- Prev
- 1
- Next